These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

416 related articles for article (PubMed ID: 26304941)

  • 1. Colchicine Acutely Suppresses Local Cardiac Production of Inflammatory Cytokines in Patients With an Acute Coronary Syndrome.
    Martínez GJ; Robertson S; Barraclough J; Xia Q; Mallat Z; Bursill C; Celermajer DS; Patel S
    J Am Heart Assoc; 2015 Aug; 4(8):e002128. PubMed ID: 26304941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation.
    Robertson S; Martínez GJ; Payet CA; Barraclough JY; Celermajer DS; Bursill C; Patel S
    Clin Sci (Lond); 2016 Jul; 130(14):1237-46. PubMed ID: 27129183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is There a Role for Colchicine in Acute Coronary Syndromes?
    Nidorf SM; Verma S
    J Am Heart Assoc; 2015 Aug; 4(8):e002372. PubMed ID: 26304942
    [No Abstract]   [Full Text] [Related]  

  • 4. A MicroRNA Signature in Acute Coronary Syndrome Patients and Modulation by Colchicine.
    Barraclough JY; Joglekar MV; Januszewski AS; Martínez G; Celermajer DS; Keech AC; Hardikar AA; Patel S
    J Cardiovasc Pharmacol Ther; 2020 Sep; 25(5):444-455. PubMed ID: 32356454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Colchicine for acute and chronic coronary syndromes.
    Imazio M; Andreis A; Brucato A; Adler Y; De Ferrari GM
    Heart; 2020 Oct; 106(20):1555-1560. PubMed ID: 32611559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Role of Colchicine in Acute Coronary Syndromes.
    Vaidya K; Martínez G; Patel S
    Clin Ther; 2019 Jan; 41(1):11-20. PubMed ID: 30185392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colchicine as a Novel Therapy for Suppressing Chemokine Production in Patients With an Acute Coronary Syndrome: A Pilot Study.
    Tucker B; Kurup R; Barraclough J; Henriquez R; Cartland S; Arnott C; Misra A; Martínez G; Kavurma M; Patel S
    Clin Ther; 2019 Oct; 41(10):2172-2181. PubMed ID: 31409556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of ramipril on serum monocyte chemoattractant protein 1, interleukin-18, and interleukin-10 in elderly patients with acute coronary syndrome.
    Chen HQ; Tan HY; Yang YW; Qiu L; Liu XQ
    Heart Vessels; 2010 Mar; 25(2):77-81. PubMed ID: 20339966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Colchicine Therapy and Plaque Stabilization in Patients With Acute Coronary Syndrome: A CT Coronary Angiography Study.
    Vaidya K; Arnott C; Martínez GJ; Ng B; McCormack S; Sullivan DR; Celermajer DS; Patel S
    JACC Cardiovasc Imaging; 2018 Feb; 11(2 Pt 2):305-316. PubMed ID: 29055633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins.
    Altaf A; Qu P; Zhao Y; Wang H; Lou D; Niu N
    Coron Artery Dis; 2015 Aug; 26(5):409-21. PubMed ID: 25946654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lutein exerts anti-inflammatory effects in patients with coronary artery disease.
    Chung RWS; Leanderson P; Lundberg AK; Jonasson L
    Atherosclerosis; 2017 Jul; 262():87-93. PubMed ID: 28527371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelets, inflammation and anti-inflammatory drugs in ACS and CAD.
    Schrör K; Huber K
    Thromb Haemost; 2015 Aug; 114(3):446-8. PubMed ID: 26288949
    [No Abstract]   [Full Text] [Related]  

  • 13. Interactions between pro-inflammatory cytokines and statins on depression in patients with acute coronary syndrome.
    Kim SW; Kang HJ; Bae KY; Shin IS; Hong YJ; Ahn YK; Jeong MH; Berk M; Yoon JS; Kim JM
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jan; 80(Pt C):250-254. PubMed ID: 28689006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute coronary syndrome and acute kidney injury: role of inflammation in worsening renal function.
    Ortega-Hernández J; Springall R; Sánchez-Muñoz F; Arana-Martinez JC; González-Pacheco H; Bojalil R
    BMC Cardiovasc Disord; 2017 Jul; 17(1):202. PubMed ID: 28747177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Beneficial Therapy with Colchicine for Atherosclerosis via Anti-inflammation and Decrease in Hypertriglyceridemia.
    Spartalis M; Spartalis E; Tzatzaki E; Tsilimigras DI; Moris D; Kontogiannis C; Kaminiotis VV; Paschou SA; Chatzidou S; Siasos G; Voudris V; Iliopoulos DC
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):74-80. PubMed ID: 30526472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NT-proBNP and CA 125 levels are associated with increased pro-inflammatory cytokines in coronary sinus serum of patients with chronic heart failure.
    Stanciu AE; Stanciu MM; Vatasescu RG
    Cytokine; 2018 Nov; 111():13-19. PubMed ID: 30098475
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory patterns in Takotsubo cardiomyopathy and acute coronary syndrome: A propensity score matched analysis.
    Santoro F; Costantino MD; Guastafierro F; Triggiani G; Ferraretti A; Tarantino N; Saguner A; Di Biase M; Brunetti ND
    Atherosclerosis; 2018 Jul; 274():157-161. PubMed ID: 29783063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of colchicine on major adverse cardiac events in next 6-month period after acute coronary syndrome occurrence; a randomized placebo-control trial.
    Akrami M; Izadpanah P; Bazrafshan M; Hatamipour U; Nouraein N; Drissi HB; Manafi A
    BMC Cardiovasc Disord; 2021 Dec; 21(1):583. PubMed ID: 34876021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum levels of interleukin-6 (Il-6), interleukin-18 (Il-18) and C-reactive protein (CRP) in patients with type-2 diabetes and acute coronary syndrome without ST-segment elevation.
    Souza JR; Oliveira RT; Blotta MH; Coelho OR
    Arq Bras Cardiol; 2008 Feb; 90(2):86-90. PubMed ID: 18392379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced thrombin activatable fibrinolysis inhibitor and enhanced proinflammatory cytokines in acute coronary syndrome.
    Pang H; Zhang C; Liu F; Gong X; Jin X; Su C
    Med Intensiva; 2017 Nov; 41(8):475-482. PubMed ID: 28038785
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.